Norfolk, VA, United States of America

Gary D Hodgen

This inventor holds 23 USPTO granted patents, plus 4 CIPO patents, primarily in Hormonal Contraception. Top assignees: The Medical College of Hampton Roads, Eastern Virginia Medical School, Serono Laboratories, Inc.. Active years: 1983-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary D Hodgen. Retrieved from https://idiyas.com/inventor/gary-d-hodgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 1.2

ph-index = 11

Forward Citations = 470(Granted Patents)


Location History:

  • Potomac, MD (US) (1983 - 1989)
  • Virginia Beach, VA (US) (1997 - 2008)
  • Norfolk, VA (US) (1988 - 2010)

Company Filing History:


Years Active: 1983-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Antiprogestin
Oral Contraception
Hormone Replacement Therapy
Fertility Assay
Selective Estrogen Receptor Modulators
GnRH Antagonist
Ovarian Estrogen
In Vitro Fertilization
Menstrual Regulation
Corticoid Therapy
Breakthrough Bleeding
Mammography
23 patents (USPTO):Explore Patents

Title: Innovations of Gary D. Hodgen: Pioneering Antiprogestin Methods

Introduction: Gary D. Hodgen is an accomplished inventor based in Norfolk, Virginia, with an impressive portfolio of 23 patents. His inventive contributions primarily focus on improving hormonal regimens by leveraging antiprogestin methods. These innovations offer significant advancements in women's health, particularly concerning hormone replacement therapy and contraception.

Latest Patents: Among his latest patents, Gary D. Hodgen has developed an antiprogestin method for reducing the side effects associated with low dosage hormone replacement therapy (HRT) and oral contraception. This innovative approach enables menses regulation and effective contraception at low doses of estrogen and progestin, mitigating issues like breakthrough bleeding and withdrawal amenorrhea. Additionally, he has created an antiprogestin method and kit specifically designed to manage these side effects while also regulating menses, enhancing the overall user experience.

Career Highlights: Throughout his career, Gary has worked with notable institutions such as the Medical College of Hampton Roads and Eastern Virginia Medical School. His extensive research and development efforts in these settings have led to groundbreaking advancements in the applications of antiprogestins in clinical practices.

Collaborations: Gary has collaborated with esteemed professionals in the field, including Edward Wellner and Maria Michejda. Their combined expertise has contributed to the success of his innovative projects and patents.

Conclusion: Gary D. Hodgen’s contributions to the field of women's health through his innovative antiprogestin methods showcase his commitment to improving quality of life through scientific advancements. His patents not only reflect his creativity but also highlight the importance of collaborative efforts in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…